Intraumbilical oxytocin injection in treatment of retained placenta

Aim: Evaluation the effect of intraumbilical oxytocin injection(modified Mojon-Gabastou methods) in a treatment of retained placenta(placenta adhaerens).Material and methods:This study included 60 mothers with retained placenta. The women were divided into two groups: group 1 (n=47) were administered 20 UI Syntocinon in 20 mL 0, 9% Na Cl saline intraumbilically into the vein(IUV) and group 2 (n=13) received intravenously metilergometrin 0, 2 mg with umbilical cord drainage and Crede method for placental expresion. Intraumbilical injection was used 30-45 min after delivery and distal cord segment clamping to the umbilical vein. Results: In group 1, placental expulsion within 60 min of IUV oxytocin injection occurred in 38(80, 8%) women ; in group 2, placental expulsion was recorded in 4(30, 7%). Manual lysis of the placenta was performed in 9 group 1, and 9 four group 2 women. Complications in terms of major hemorrhage were not observed in group 1, whereas a hemorrhage of>500 mL was recorded in 2 group 2. Conclusions: Intraumbilical oxytocin injection is safe, non-surgical, non agressive, not associated with allergic reaction, method for the treatment of the retained placenta.